Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitro.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Arthritis & Rheumatism

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/art.30317PMID 21425122PMCID PMC3134600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.

  2010cited by this paper
• Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies

  2010cited by this paper
• Is scleroderma a vasculopathy?

  2009cited by this paper
• TGF-β-induced epithelial to mesenchymal transition

  2009cited by this paper
• Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.

  2009cited by this paper
• A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition

  2009cited by this paper
• Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

  2009cited by this paper
• Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy.

  2009cited by this paper
• Transforming growth factor-beta in systemic sclerosis (scleroderma).

  2009cited by this paper
• Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.

  2009cited by this paper
• Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives.

  2009influential reference
• Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?

  2008cited by this paper
• A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis.

  2008cited by this paper
• Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells

  2008cited by this paper
• Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

  2008cited by this paper
• Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations

  2007cited by this paper
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis

  2007cited by this paper
• Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.

  2007cited by this paper
• Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal Transitions

  2007cited by this paper
• Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.

  2007cited by this paper
• Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.

  2005cited by this paper
• TGF-beta and epithelial-to-mesenchymal transitions.

  2005cited by this paper
• Isolation and culture of primary endothelial cells.

  2005cited by this paper
• Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development.

  2005cited by this paper
• The Snail genes as inducers of cell movement and survival: implications in development and cancer

  2005influential reference
• Switching on-off Snail: LOXL2 versus GSK3beta.

  2005cited by this paper
• Pathologic assessment of vasculopathies in pulmonary hypertension.

  2004cited by this paper
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004cited by this paper
• Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

  2004cited by this paper
• Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.

  2003cited by this paper
• Cardiac-allograft vasculopathy.

  2003cited by this paper
• BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury

  2003cited by this paper
• Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts.

  2001influential reference
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000cited by this paper
• Isolation of endothelial cells from murine tissue.

  2000cited by this paper
• Cardiac allograft vasculopathy

  2000cited by this paper
• Autoimmunity and vascular involvement in systemic sclerosis (SSc).

  1999cited by this paper
• TGF- and fibrosis

  1999cited by this paper
• Autoimmunity and Vascular Involvement in Systemic Sclerosis (SSc)

  1999cited by this paper
• TGF-beta and fibrosis.

  1999cited by this paper
• The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal Transition

  1997cited by this paper
• Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein

  1984cited by this paper

• Systemic sclerosis: pathogenic mechanisms and their implications for treatment

  2025cites this paper
• Role of Growth Factors in the Pathogenesis of Systemic-Sclerosis-Associated Fibrosis

  2025cites this paper
• Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition

  2024cites this paper
• Endothelial CD38-induced endothelial-to-mesenchymal transition is a pivotal driver in pulmonary fibrosis

  2024cites this paper
• The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know.

  2024cites this paper
• Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities

  2023cites this paper
• Extracellular matrix remodelling in obesity and metabolic disorders

  2023cites this paper
• PKCδ regulates the vascular biology in diabetic atherosclerosis

  2023cites this paper
• Systemic sclerosis interstitial lung disease: unmet needs and potential solutions

  2023cites this paper
• Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis.

  2023cites this paper
• The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity

  2023cites this paper
• Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge

  2022cites this paper
• Low-Dose X-Ray Increases Paracellular Permeability of Human Renal Glomerular Endothelial Cells

  2022cites this paper
• Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling

  2022cites this paper
• New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy

  2021cites this paper
• Tyrosine Kinases in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis and Potential Therapeutic Role of their Inhibition.

  2021cites this paper
• Endothelial‐to‐mesenchymal transition in systemic sclerosis

  2021cites this paper
• Mitomycin C induces pulmonary vascular endothelial‐to‐mesenchymal transition and pulmonary veno‐occlusive disease via Smad3‐dependent pathway in rats

  2020cites this paper
• Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis.

  2020cites this paper
• Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis

  2020cites this paper
• Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis.

  2019cites this paper
• Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

  2019cites this paper
• Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction.

  2019cites this paper
• Endothelium-mediated contributions to fibrosis.

  2019cites this paper
• Active roles of dysfunctional vascular endothelium in fibrosis and cancer

  2019cites this paper
• Microparticles in systemic sclerosis, targets or tools to control fibrosis: This is the question!

  2019cites this paper
• The Primary Cilium: Emerging Role as a Key Player in Fibrosis

  2019cites this paper
• Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies

  2019cites this paper
• Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation

  2019cites this paper
• Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease

  2018cites this paper
• Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin

  2018cites this paper
• Oral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs

  2018influential citation
• The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway

  2018influential citation
• LncRNAs: Proverbial Genomic “Junk” or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?

  2018cites this paper
• A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis

  2018cites this paper
• The therapeutic potential of targeting the endothelial-to-mesenchymal transition

  2018cites this paper
• Endothelial–mesenchymal transition in atherosclerosis

  2018cites this paper
• Material Strategies for Modulating Epithelial to Mesenchymal Transitions.

  2017cites this paper
• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

  2017cites this paper
• Is There a Potential Therapeutic Role for Caveolin-1 in Fibrosis?

  2017cites this paper
• Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)

  2017influential citation
• Caveolin-1 De fi ciency Induces Spontaneous Endothelial-to-Mesenchymal Transition in Murine Pulmonary Endothelial Cells in Vitro

  2017cites this paper
• Accelerated Endothelial to Mesenchymal Transition Increased Fibrosis via Deleting Notch Signaling in Wound Vasculature.

  2017cites this paper
• Dihydroartemisinin up‐regulates VE‐cadherin expression in human renal glomerular endothelial cells

  2017cites this paper
• TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases

  2017cites this paper
• Osteopontin–integrin engagement induces HIF-1α–TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer

  2017cites this paper
• Pathophysiology of Fibrosis in Systemic Sclerosis

  2017cites this paper
• Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities

  2017cites this paper
• The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis

  2017cites this paper
• Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis

  2017cites this paper
• Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?

  2016influential citation
• Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases

  2016cites this paper
• Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1

  2016cites this paper
• Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis

  2016cites this paper
• The Scenario : Damage and Remodelling of the Microvasculature in Systemic Sclerosis

  2016cites this paper
• Valve Endothelial Cells - Not Just Any Old Endothelial Cells.

  2016cites this paper
• Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis.

  2016cites this paper
• Cellular interactions in the pathogenesis of interstitial lung diseases

  2015cites this paper
• A role for partial endothelial-mesenchymal transitions in angiogenesis?

  2015cites this paper
• A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome

  2015influential citation
• Vasculopathy in scleroderma

  2015cites this paper
• Pathogenesis of Systemic Sclerosis

  2015cites this paper
• Advanced Glycation End Products Induce Endothelial-to-Mesenchymal Transition via Downregulating Sirt 1 and Upregulating TGF-β in Human Endothelial Cells

  2015cites this paper
• Endothelial and smooth muscle cell transformation in atherosclerosis

  2015cites this paper
• Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis–Associated Interstitial Lung Disease

  2015cites this paper
• Endothelial cells expressing endothelial and mesenchymal cell gene products in Systemic Sclerosis-associated interstitial lung disease lung tissues

  2015cites this paper
• Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway

  2015cites this paper
• Nuclear Translocation of β‐Catenin Mediates the Parathyroid Hormone‐Induced Endothelial‐to‐Mesenchymal Transition in Human Renal Glomerular Endothelial Cells

  2014cites this paper
• Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor

  2014cites this paper
• A Novel Controlled Release Platform For In Situ Vascular Tissue Engineering

  2014cites this paper
• Endothelial regulation of extracellular matrix in the aortic valve

  2014cites this paper
• Adult Lung Stem Cells

  2014cites this paper
• Transforming Growth Factor-β1 Inhibits Trophoblast Cell Invasion by Inducing Snail-mediated Down-regulation of Vascular Endothelial-cadherin Protein*

  2013cites this paper
• TGF-β and Cardiovascular Disorders

  2013cites this paper
• Role of endothelial-mesenchymal transition in idiopathic portal hypertension.

  2013cites this paper
• Review: evidence that systemic sclerosis is a vascular disease.

  2013cites this paper
• TGF-β in Human Disease

  2013cites this paper
• Disease modification in systemic sclerosis

  2013cites this paper
• Interferon‐γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)‐1 and transforming growth factor (TGF) β2

  2013influential citation
• Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro.

  2013cites this paper
• The immunology of fibrosis.

  2013cites this paper
• Getting Out of a Sticky Situation: Targeting the Myofibroblast in Scleroderma

  2012cites this paper
• Mechanism of Fibrosis

  2012cites this paper
• Endocardial and Epicardial Epithelial to Mesenchymal Transitions in Heart Development and Disease

  2012cites this paper
• Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

  2012cites this paper
• Targeting the tumor stroma as a novel therapeutic approach for prostate cancer.

  2012cites this paper
• Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases

  2012cites this paper
• The Role of TGF-β Receptors in Fibrosis

  2012cites this paper
• Low-dose imatinib in the treatment of severe systemic sclerosis: a case series of six Chinese patients and literature review

  2012cites this paper
• 1 Pathogenesis of the Endothelial Damage and Related Factors

  2012cites this paper
• Pathogenesis of the Endothelial Damage and Related Factors

  2012cites this paper
• Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

  2012cites this paper
• Regulation of endothelial cell plasticity by TGF-β

  2011cites this paper
• Estudo da vasculopatia pulmonar no modelo experimental de esclerodermia induzido pelo colágeno do tipo V

  2011cites this paper
• Regulation of endothelial cell plasticity by TGF-β

  2011cites this paper
• Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies

  2011cites this paper
• Tyrosine kinase inhibitor therapy for systemic sclerosis: Quo Vadis?

  2011cites this paper
• Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.

  2011cites this paper
• The origin of the myofibroblast in fibroproliferative vasculopathy: does the endothelial cell steer the pathophysiology of systemic sclerosis?

  2011cites this paper